Induction of telomerase activity during development of human mast cells from peripheral blood cd34+ cells: Comparisons with tumor mast-cell lines

Journal of Immunology

Volumn 166, Issue 11, 2001, Pages 6647-6656

  Chaves Dias, Cristina ^a,c   Hundley, Thomas R ^a   Gilfillan, Alasdair M ^b   Kirshenbaum, Arnold S ^b   Cunha Melo, Jose Renan ^a,d   Metcalfe, Dean D ^b   Beaven, Michael A ^a,e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; TELOMERASE;

ARTICLE; CELL DIVISION; ENZYME INDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0035337499     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.11.6647     Document Type: Article

References (75)

1. +, and expresses aminopeptidase N (CD13). Blood 94:2333.
2. Li, L., X.-T. Zhang, and S. A. Krilis. 1999. Factors that affect human mast cell and basophil growth. In E. Razin and J. Rivera, eds. Signal Transduction in Mast Cells and Basophils. Springer-Verlag, New York, pp. 54.
3. Galli, S. J., M. Tsai, and C. S. Lantz. 1999. The regulation of mast cell and basophil development by kit ligand, SCF, and IL-3. In E. Razin and J. Rivera, eds. Signal Transduction in Mast Cells and Basophils. Springer-Verlag, New York, pp. 11.
4. Serve, H., N. S. Yee, G. Stella, L. Sepp-Lorenzino, J. C. Tan, and P. Besmer. 1995. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14:473.
5. v c-kit induces mast cell adhesion and chemotaxis. Am. J. Physiol. 275:C1291.
6. Timokhina, I., H. Kissel, G. Stella, and P. Besmer. 1998. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J. 17:6250.
7. Ishizuka, T., K. Chayama, K. Takeda, E. Hamelmann, N. Terada, G. M. Keller, G. L. Johnson, and E. W. Gelfand. 1999. Mitogen-activated protein kinase activation through Fc∈ receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol. 162:2087.
8. Foltz, I. A., J. C. Lee, P. R. Young, and J. W. Schrader. 1997. Hematopoietic growth factors with the exception of interleukin-4 activated p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 272:3296.
9. Linnekin, D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 31:1053.
10. de Groot, R. P., P. F. Coffer, and L. Koenderman. 1998. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell. Signalling 10:619.
11. Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16:249.
12. Globerson, A. 1999. Hematopoietic stem cells and aging. Exp. Gerontol. 34:137.
13. Blackburn, E. H. 1992. Telomerases. Annu. Rev. Biochem. 61:113.
14. Holt, S. E., and J. W. Shay. 1999. Role of telomerase in cellular proliferation and cancer. J. Cell. Physiol. 180:10.
15. Weng, N.-P., K. S. Hathcock, and R. J. Hodes. 1998. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 9:151.
16. Yiu, J., C.-P. Chiu, and P. M. Lansdorp. 1998. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 91:3255.
17. Engelhardt, M., R. Kumar, J. Albanell, R. Pettengell, W. Han, and M. A. S. Moore. 1997. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182.
18. Buchkovich, K. J., and C. W. Greider. 1996. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell 7:1443.
19. Liu, J.-P. 1999. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 13:2091.
20. Wu, K. J., C. Grandori, M. Amacker, N. Simon-Vermot, A. Polack, J. Lingner, and R. Dalla-Favera. 1999. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21:220.
21. Hu, B. T., and R. A. Insel. 1999. Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase subunit. Eur. J. Immunol. 29:3745.
22. Bodnar, A. G., N. W. Kim, R. B. Effros, and C.-P. Chiu. 1996. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228:58.
23. Buchkovich, K. J., and C. W. Greider. 1996. Telomerase regulation during entry into the cell cycle. Mol. Biol. Cell 7:1443.
24. Weng, N.-P., L. Granger, and R. J. Hodes. 1997. Teleomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. USA 94:10827.
25. Li, H., L. Zhao, Z. Yang, J. W. Funder, and J.-P. Liu. 1998. Telomerase is controlled by protein kinase Cα in human breast cancer cells. J. Biol. Chem. 273:33436.
26. Kang, S. S., T. Kwon, D. Y. Kwon, and S. I. Do. 1999. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274:13085.
27. Barsumian, E. L., C. Isersky, M. G. Petrino, and R. P. Siraganian. 1981. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur. J. Immunol. 11:317.
28. Maeyama, K., R. J. Hohman, H. Metzger, and M. A. Beaven. 1986. Quantitative relationships between aggregation of IgE receptors, generation of intracellular signals, and histamine secretion in rat basophilic leukemia (2H3) cells: enhanced responses with heavy water. J. Biol. Chem. 261:2583.
29. Yoshikawa, H., Y. Nakajima, and K. Tasaka. 1999. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM expression. J. Immunol. 162:6162.
30. Butterfield, J. H., D. Weiler, G. Dewald, and G. J. Gleich. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12:345.
31. Kimura, I., Y. Moritani, and Y. Tanizaki. 1973. Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy 3:195.
32. Choi, O. H., J. H. Lee, T. Kassessinoff, J. R. Cunha-Melo, S. V. P. Jones, and M. A. Beaven. 1993. Carbachol and antigen mobilize calcium by similar mechanisms in a transfected mast cell line (RBL-2H3 cells) that expresses m1 muscarinic receptors. J. Immunol. 151:5586.
33. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
34. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
35. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.
36. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
37. Kendel, E. S., and N. Hay. 1999. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253:210.
38. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38-mitogen protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420.
39. Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell Biol. 16:1247.
40. Berra, E., M. T. Diaz-Meco, and J. Moscat. 1998. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J. Biol. Chem. 273:10792.
41. Clerk, A., and P. H. Sugden. 1998. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 426:93.
42. Whitmarsh, A. J., S. H. Yang, M. S. Su, A. D. Sharrocks, and R. J. Davis. 1997. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:2360.
43. Mitchison, J. M., and B. L. Carter. 1975. Cell cycle analysis. Methods Cell Biol. 11:201.
44. Hesketh, T. R., M. A. Beaven, J. Rogers, B. Burke, and G. B. Warren. 1984. Stimulated release of histamine by a rat mast cell line is inhibited during mitosis. J. Cell Biol. 98:2250.
45. Bayer, B. M., T. N. Lo, and M. A. Beaven. 1980. Anti-inflammatory drugs alter amino acid transport in HTC cells. J. Biol. Chem. 255:8784.
46. Holt, S. E., D. L. Aisner, J. W. Shay, and W. E. Wright. 1997. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA 93:10687.
47. Cissel, D. S., and M. A. Beaven. 2000. Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J. Biol. Chem. 275: 7066.
48. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268:9194.
49. Bradshaw, D., C. H. Hill, J. S. Nixon, and S. E. Wilkinson. 1993. Therapeutic potential of protein kinase C inhibitors. Agents Actions. 38:135.
50. Gabbay, R. A., C. Sutherland, L. Gnudi, B. B. Kahn, R. M. O'Brien, D. K. Granner, and J. S. Flier. 1996. Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the ras/mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271:1890.
51. Linnekin, D., C. S. DeBerry, and S. Mou. 1997. Lyn associates with the juxtamembrane region of c-Kit and is activated by stem cell factor in hematopoietic cell lines and normal progenitor cells. J. Biol. Chem. 272:27450.
52. Oliver, J. M., D. L. Burg, B. S. Wilson, J. L. McLaughlin, and R. L. Geahlen. 1994. Inhibition of mast cell Fc∈-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem. 269:29697.
53. Peters, J. D., M. T. Furlong, D. J. Asai, M. L. Harrison, and R. L. Geahlen. 1996. Syk, activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it interacts with and phosphorylates alpha-tubulin on tyrosine. J. Biol. Chem. 271:4755.
54. Levitzki, A. 1999. Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol. Ther. 82:231.
55. Toledo, L. M., and N. B. Lydon. 1997. Structures of staurosporine bound to CDK2 and cAPK-new tools for structure-based design of protein kinase inhibitors. Structure 5:1551.
56. Peirce, M. J., M. R. Munday, and P. T. Peachell. 1999. Role of protein phosphatases in the regulation of human mast cell and basophil function. Am. J. Physiol. 277:C1021.
57. Hagiwara, M., S. Inoue, T. Tanaka, K. Nunoki, M. Ito, and H. Hidaka. 1988. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem. Pharmacol. 37:2987.
58. i GTP-binding proteins linked to a phospholipase C signaling pathway. J. Immunol. 160:5136.
59. Marks, P. A., V. M. Richon, R. Breslow, and R. A. Rifkind. 1999. Hybrid polar inducers of transformed cell differentiation/apoptosis: from the cell to the clinic. C. R. Acad. Sci. 322:161.
60. Albanell, J., W. Han, B. Mellado, R. Gunawardane, H. I. Scher, E. Dmitrovsky, and M. A. Moore. 1996. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res. 56: 1503.
61. Zhang, Z., E. C. Liong, T. Y. Lau, K. M. Leung, P. C. Fung, and G. L. Tipoe. 2000. Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation. Int. J. Oncol. 16:887.
62. O'Farrell, A. M., M. Ichihara, A. L. Mui, and A. Miyajima. 1996. Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response. Blood 87:3655.
63. Brizzi, M. F., M. G. Zini, M. G. Aronica, J. M. Blechman, Y. Yarden, and L. Pegoraro. 1994. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on Jak2 tyrosine kinase. J. Biol. Chem. 269:31680.
64. Pearson, M. A., A. O'Farrell, T. M. Dexter, A. D. Whetton, P. J. Owen-Lynch, and C. M. Heyworth. 1998. Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy. Growth Factors 15:293.
65. Park, J., L. Tadlock, G. J. Gores, and T. Patel. 1999. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholaniocarcinoma cell line. Heptology 30:1128.
66. Igarashi, H., and N. Sakaguchi. 1997. Telomerase activity in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 89:1299.
67. Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. 1996. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183:2471.
68. Igarashi, H., and N. Sakaguchi. 1996. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem. Biophys. Res. Commun. 219:649.
69. Chui, C.-P., W. Dragowska, N. W. Kim, H. Vaziri, J. Yui, T. Thomas, C. B. Harley, and P. M. Lansdorp. 1996. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14:239.
70. Moriyama, Y., T. Tsujimura, K. Hashimoto, M. Morimoto, H. Kitayama, Y. Matsuzawa, Y. Kitamura, and Y. Kanakura. 1996. Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase. J. Biol. Chem. 271:3347.
71. Kitayama, H., T. Tsujimura, I. Matsumura, K. Oritani, H. Ikeda, J. Ishikawa, M. Okabe, M. Suzuki, K. Yamamura, Y. Matsuzawa, et al. 1996. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88:995.
72. Marks, P. A., V. M. Richon, and R. A. Rifkind. 1996. Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: molecular and clinical studies employing hybrid polar compounds. Int. J. Hematol. 63:1.
73. Richon, V. M., S. Emilliani, E. Verdin, Y. Webb, R. Breslow, R. A. Rifkind, and P. A. Marks. 1998. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. USA 95:3003.
74. Bodnar, A. G., M. Quellette, M. Frolkis, S. E. Holt, C.-P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349.
75. Counter, C. M., W. C. Hahn, W. Wei, S. D. Caddle, R. L. Beijersbergen, P. M. Lansdorp, J. M. Sedivy, and R. A. Weinberg. 1998. Dissociation among in vivo telomerase activity, telomere maintenance, and cellular immortalization, Proc. Natl. Acad. Sci. USA 95:14723.